Analysis
Republican Senator Bernie Moreno sent Anthropic CEO Dario Amodei a letter this week accusing him of an "alarmist approach" and "panic-inducing commentary" on AI, Axios reported October 5. The letter lands days before Anthropic's expected IPO, with valuation estimates running as high as nearly $2 trillion.
Moreno's specific argument is a tension he says Amodei can't resolve: how can Amodei ask ordinary Americans to invest their savings in Anthropic's public offering while also agreeing with "doomer" predictions that the company's own product could kill humans? Moreno wrote that Amodei's own comments "indicate that your instinct is to wreak havoc on the public SI discourse," using the increasingly common shorthand "SI" for superintelligence. He urged Anthropic to spend more time talking about how AI can strengthen national security and keep the US ahead of China, rather than emphasizing existential risk.
“He urged Anthropic to spend more time talking about how AI can strengthen national security and keep the US ahead of China, rather than emphasizing existential risk.”
This isn't an isolated shot. Moreno's letter is the latest in a string of attacks from Trump-aligned officials on Amodei specifically -- the same week Anthropic's own IPO filings reportedly devote roughly a third of their risk disclosures to existential AI scenarios, and three former AI researchers testified to the New York City Council that humanity is more likely than not to lose control of advanced AI systems. Moreno and the city council are arguing past each other: one side says the risk messaging is overblown and politically convenient, the other says the labs aren't taking it seriously enough. Anthropic is caught directly between both critiques in the same week it's trying to close a historic IPO.
For Anthropic, the practical risk isn't that Moreno's letter changes any near-term policy -- it's that a sitting senator publicly challenging the CEO's credibility on safety messaging, in writing, during an active IPO roadshow, gives short sellers and skeptical analysts a ready-made talking point once the stock starts trading. OpenAI's decision to pause parts of its own public offering over safety concerns -- a move some attributed to weaker financial metrics rather than principle -- makes Anthropic's choice to proceed with its listing look either more confident or more exposed, depending on how this political fight plays out over the next month.
Anthropic has not publicly responded to the letter.
